H.m. Heywood & Sons
Private Unlimited Company · Wells
ActiveUnited KingdomIncorporated 1970Private Unlimited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2023-06-30
IXBRL · 70 source facts · 20 selected values
Validation findingsXBRL valid
Accounts to 2023-06-30
IXBRL · 70 source facts · 20 selected values
Validation findings
XBRL valid
- Reporting period
- 2022-07-01 to 2023-06-30
- Extraction status
- complete
- Numeric facts
- 24
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2024-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2509_00969399_20230630
- Source archive
- Accounts_Monthly_Data-September2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2022-06-30
IXBRL · 132 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2022-06-30
IXBRL · 132 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2021-07-01 to 2022-06-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 70
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- secr-frs-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0033_00969399_20220630
- Source archive
- Accounts_Monthly_Data-November2023.zip
Registered details
00969399- Status
- Active
- Type
- Private Unlimited Company
- Incorporated
- 1970-01-01
- Jurisdiction
- —
- Registered office
- 20 CHAMBERLAIN STREET, WELLS, SOMERSET, BA5 2PF, UNITED KINGDOM
Classification
1 SIC codes13006
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
1 matched grantsBioFlow Phase 2LiveInnovate UK · Collaborative R&D · 2025-12-01 – 2027-11-30 · with 1 other participant£8,110awarded
BioFlow Phase 2Live
Innovate UK · Collaborative R&D · 2025-12-01 – 2027-11-30 · with 1 other participant
£8,110
awarded
H.m. Heywood & Sons£8,110